These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 19923038)

  • 21. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
    Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pioglitazone, a PPARgamma agonist, restores endothelial function in aorta of streptozotocin-induced diabetic rats.
    Majithiya JB; Paramar AN; Balaraman R
    Cardiovasc Res; 2005 Apr; 66(1):150-61. PubMed ID: 15769458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with metformin.
    Derosa G; D'Angelo A; Ragonesi PD; Ciccarelli L; Piccinni MN; Pricolo F; Salvadeo SA; Montagna L; Gravina A; Ferrari I; Paniga S; Cicero AF
    Intern Med J; 2007 Feb; 37(2):79-86. PubMed ID: 17229249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
    Rosenstock J; Brazg R; Andryuk PJ; Lu K; Stein P;
    Clin Ther; 2006 Oct; 28(10):1556-68. PubMed ID: 17157112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between congestive heart failure and hospitalization in patients with type 2 diabetes mellitus receiving treatment with insulin or pioglitazone: a retrospective data analysis.
    Rajagopalan R; Rosenson RS; Fernandes AW; Khan M; Murray FT
    Clin Ther; 2004 Sep; 26(9):1400-10. PubMed ID: 15531002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intranasal insulin improves cognition and modulates beta-amyloid in early AD.
    Reger MA; Watson GS; Green PS; Wilkinson CW; Baker LD; Cholerton B; Fishel MA; Plymate SR; Breitner JC; DeGroodt W; Mehta P; Craft S
    Neurology; 2008 Feb; 70(6):440-8. PubMed ID: 17942819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pioglitazone for the treatment of Alzheimer's disease.
    Galimberti D; Scarpini E
    Expert Opin Investig Drugs; 2017 Jan; 26(1):97-101. PubMed ID: 27885860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Pioglitazone for Secondary Stroke Prevention in Patients with Impaired Glucose Tolerance and Newly Diagnosed Diabetes: The J-SPIRIT Study.
    Tanaka R; Yamashiro K; Okuma Y; Shimura H; Nakamura S; Ueno Y; Tanaka Y; Miyamoto N; Tomizawa Y; Nakahara T; Furukawa Y; Watada H; Kawamori R; Hattori N; Urabe T
    J Atheroscler Thromb; 2015; 22(12):1305-16. PubMed ID: 26269002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Possible role of rice bran extract in microglial modulation through PPAR-gamma receptors in alzheimer's disease mice model.
    El-Din SS; Abd Elwahab S; Rashed L; Fayez S; Aboulhoda BE; Heikal OA; Galal AF; Nour ZA
    Metab Brain Dis; 2021 Oct; 36(7):1903-1915. PubMed ID: 34043126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PPAR-gamma agonist pioglitazone modifies craving intensity and brain white matter integrity in patients with primary cocaine use disorder: a double-blind randomized controlled pilot trial.
    Schmitz JM; Green CE; Hasan KM; Vincent J; Suchting R; Weaver MF; Moeller FG; Narayana PA; Cunningham KA; Dineley KT; Lane SD
    Addiction; 2017 Oct; 112(10):1861-1868. PubMed ID: 28498501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized pilot clinical trial of the safety of pioglitazone in treatment of patients with Alzheimer disease.
    Geldmacher DS; Fritsch T; McClendon MJ; Landreth G
    Arch Neurol; 2011 Jan; 68(1):45-50. PubMed ID: 20837824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peroxisome proliferator-activated receptor-gamma agonists for Alzheimer's disease and amnestic mild cognitive impairment: a systematic review and meta-analysis.
    Liu J; Wang LN; Jia JP
    Drugs Aging; 2015 Jan; 32(1):57-65. PubMed ID: 25504005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PPAR-γ agonism as a modulator of mood: proof-of-concept for pioglitazone in bipolar depression.
    Kemp DE; Schinagle M; Gao K; Conroy C; Ganocy SJ; Ismail-Beigi F; Calabrese JR
    CNS Drugs; 2014 Jun; 28(6):571-81. PubMed ID: 24715548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The peroxisome proliferators activated receptor-gamma agonists as therapeutics for the treatment of Alzheimer's disease and mild-to-moderate Alzheimer's disease: a meta-analysis.
    Cheng H; Shang Y; Jiang L; Shi TL; Wang L
    Int J Neurosci; 2016; 126(4):299-307. PubMed ID: 26001206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Insulin sensitizing drugs].
    Smahelová A
    Vnitr Lek; 2009 Apr; 55(4):425-8. PubMed ID: 19449763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of the PPAR-gamma agonist pioglitazone on plasma concentrations of circulating vasoactive factors in type II diabetes mellitus.
    de Boer RA; Martens FM; Kuipers I; Boomsma F; Visseren FL
    J Hum Hypertens; 2010 Jan; 24(1):74-6. PubMed ID: 19847195
    [No Abstract]   [Full Text] [Related]  

  • 37. Multi-Target Neuroprotection of Thiazolidinediones on Alzheimer's Disease via Neuroinflammation and Ferroptosis.
    Yang J; Shi X; Wang Y; Ma M; Liu H; Wang J; Xu Z
    J Alzheimers Dis; 2023; 96(3):927-945. PubMed ID: 37927258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rivoglitazone: a new thiazolidinedione for the treatment of type 2 diabetes mellitus.
    Koffarnus RL; Wargo KA; Phillippe HM
    Ann Pharmacother; 2013 Jun; 47(6):877-85. PubMed ID: 23632280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repeated Intraportal Injection of Mesenchymal Stem Cells in Combination with Pioglitazone in Patients with Compensated Cirrhosis: A Clinical Report of Two Cases.
    Vosough M; Moossavi S; Mardpour S; Akhlaghpoor S; Azimian V; Jarughi N; Hosseini SE; Ashrafi M; Nikfam S; Aghdami N; Malekzadeh R; Mohamadnejad M; Baharvand H
    Arch Iran Med; 2016 Feb; 19(2):131-6. PubMed ID: 26838084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sustained 4-year cognitive and functional response in early Alzheimer's disease with pioglitazone.
    Read S; Wu P; Biscow M
    J Am Geriatr Soc; 2014 Mar; 62(3):584-6. PubMed ID: 24628640
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.